| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
18 companies
Awm Investment Company, Inc. is a 10% Owner at DXLG, with reported holdings spanning 18 companies. Recent filings cover 19 purchases and 225 sales. Those positions are worth an estimated $212.1M at current prices.
Our model assigns Awm Investment Company, Inc. a strong insider score of 73/100, based on 59 past trades. Over a 12-month horizon, 62.1% of those trades were profitable, with an average 12-month return of +19.9%.
Awm Investment Company, Inc.'s largest disclosed position is in DXLG as 10% Owner, worth about $58.2M. The recent filings there lean toward selling, a net 1,711,814 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 307 | $7.25 | $2,225.75 | - | |
| Sep 1, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 550 | $7.43 | $4,086.50 | -0.2% | |
| Aug 30, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 2,300 | $7.42 | $17,073.92 | -0.7% | |
| Aug 25, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 2,566 | $7.48 | $19,205.04 | -0.8% | |
| Aug 22, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 458 | $7.84 | $3,590.79 | -0.1% | |
| Aug 17, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 755 | $7.56 | $5,711.25 | -0.2% | |
| Aug 11, 2017 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 6,093 | $7.52 | $45,789.50 | -1.9% | |
| May 11, 2017 | IDN Intellicheck, Inc. | 10% Owner | Sell | 109,975 | $3.46 | $380,870.23 | -5.5% | |
| Dec 30, 2016 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 2,310 | $8.50 | $19,635.00 | -0.7% | |
| Dec 27, 2016 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Sell | 5,752 | $8.84 | $50,837.67 | -1.7% |